N-Benzyllinolenamide
N-Benzyllinolenamide is a natural macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 41.8 μM[1].
Product Specifications
CAS Number
[883715-18-2]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; FAAH
Type
Natural Products
Related Pathways
Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/n-benzyllinolenamide.html
Purity
99.70
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC/C=C\C/C=C\C/C=C\CCCCCCCC(NCC1=CC=CC=C1)=O
Molecular Formula
C25H37NO
Molecular Weight
367.57
Precautions
H302, H315, H319, H335
References & Citations
[1]Wu H, et al. Macamides and their synthetic analogs: evaluation of in vitro FAAH inhibition. Bioorg Med Chem. 2013 Sep 1;21 (17) :5188-97.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PLEKHA8, CT (PLEKHA8, FAPP2, Pleckstrin homology domain-containing family A member 8, Phosphatidylinositol-four-phosphate adapter protein 2, Serologically defined breast cancer antigen NY-BR-86) (MaxLight 750)
PLEKHA8, CT (PLEKHA8, FAPP2, Pleckstrin homology domain-containing family A member 8, Phosphatidylinositol-four-phosphate adapter protein 2, Serologically defined breast cancer antigen NY-BR-86) (MaxLight 750)
